Cannabinoid CB2 receptor activation attenuates cytokine-evoked mucosal damage in a human colonic explant model without changing epithelial permeability-Reference-Cited by-同舟云学术

Cannabinoid CB2 receptor activation attenuates cytokine-evoked mucosal damage in a human colonic explant model without changing epithelial permeability

Published:2013-08 Issue:2 Volume:63 Page:209-217
ISSN:1043-4666
Container-title:Cytokine
language:en
Short-container-title:Cytokine

Author:

Harvey B.S.,Nicotra L.L.,Vu M.,Smid S.D.

Publisher

Elsevier BV

Subject

Molecular Biology,Hematology,Biochemistry,Immunology,Immunology and Allergy

Reference37 articles.

1. Cannabinoids and the gut: new developments and emerging concepts;Izzo;Pharmacol Ther,2010

2. The endogenous cannabinoid system protects against colonic inflammation;Massa;J Clin Invest,2004

3. Agonists of cannabinoid receptor 1 and 2 inhibit experimental colitis induced by oil of mustard and by dextran sulfate sodium;Kimball;Am J Physiol Gastrointest Liver Physiol,2006

4. Effects of cannabinoid receptor-2 activation on accelerated gastrointestinal transit in lipopolysaccharide-treated rats;Mathison;Br J Pharmacol,2004

5. The endogenous cannabinoid system in the gut of patients with inflammatory bowel disease;Di Sabatino;Mucosal Immunol,2011

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Conclusion;Anandamide in Health and Disease;2025

2. Effects of Cannabinoids on Intestinal Motility, Barrier Permeability, and Therapeutic Potential in Gastrointestinal Diseases;International Journal of Molecular Sciences;2024-06-18

3. Involvement of the cannabinoid system in chronic inflammatory intestinal diseases: opportunities for new therapies;Intestinal Research;2022-10-31

4. Phycocyanin stimulates ulcerative colitis healing via selective activation of cannabinoid receptor-2, intestinal mucosal healing, Treg accumulation, and p38MAPK/MK2 signaling inhibition;Life Sciences;2022-09

5. The semi-synthetic flavonoid 2′,3′,4′-trihydroxyflavone (2-D08) inhibits both SN-38- and cytokine-evoked increases in epithelial barrier permeability in an in vitro intestinal mucositis model;Food & Function;2022